Venous thromboembolism risk in cancer patients receiving first‐line immune checkpoint inhibitor versus chemotherapy is a research paper published in American Journal of Hematology (2023). On theSindex it has a DataRank of 0. It has been cited 14 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
American Heart Association
Grant: 857078
National Heart, Lung, and Blood Institute
Grant: K23 HL159271
NHLBI NIH HHS
Grant: R01 HL132325
Cancer Prevention and Research Institute of Texas
Grant: RR190104
NIH HHS
Grant: OT2 OD032581
Cancer Prevention and Research Institute of Texas
Grant: RR190079
FWCI
3.25
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals